Who owns Aimmune Therapeutics Inc.?

No ownership or control links for Aimmune Therapeutics Inc. are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Aimmune Therapeutics Inc.'s risk level?

WhiteIntel flags Aimmune Therapeutics Inc. as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Aimmune Therapeutics Inc. appear across sources?

Aimmune Therapeutics Inc. is indexed in the WhiteIntel corporate-ownership graph (GB), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Legal entityLow

Aimmune Therapeutics Inc.

Name: Aimmune Therapeutics Inc. — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Aimmune Therapeutics Inc., Company, GB

Aimmune Therapeutics Inc. — UK company (psc:UJhTi-c0AtpslSKFQp65MwtKvtw). 1 holding. Every claim linked to its source.

PSC UJhTi-c0AtpslSKFQp65MwtKvtwCompanyGB

Ownership graph Export .md

JSON / MCPsample

Live UK registry

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

None in current sources.

Holdings / subsidiaries

Aimmune Therapeutics Inc.
- AIMMUNE THERAPEUTICS UK LIMITED· beneficial owner87.5%· via CH PSC

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Aimmune Therapeutics Inc. — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Aimmune Therapeutics Inc. is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore GB coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Aimmune Therapeutics Inc. is behind a paywall — everything we hold on this subject is already on this page.

/02

People & control

1 party · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
AIMMUNE THERAPEUTICS UK LIMITED
Also holds roles at 1 other company
- Nestle S.A.beneficial owner

1 party · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns Aimmune Therapeutics Inc.?: No ownership or control links for Aimmune Therapeutics Inc. are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Aimmune Therapeutics Inc.'s risk level?: WhiteIntel flags Aimmune Therapeutics Inc. as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Aimmune Therapeutics Inc. appear across sources?: Aimmune Therapeutics Inc. is indexed in the WhiteIntel corporate-ownership graph (GB), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Aimmune Therapeutics Inc.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…